Kyrkogatan 24
Gothenburg 411 15
Sweden
46 18 19 49 50
https://www.slottsviken.se
Sector(s): Real Estate
Industry: Real Estate - Diversified
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Jakob Osterberg | MD, CEO & Director | N/A | N/A | 1979 |
Slottsviken Fastighetsaktiebolag (publ), a real estate company, acquires, develops, and manages properties in Sweden and internationally. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities. The company was formerly known as Conpharm AB (publ) and changed its name to Slottsviken Fastighetsaktiebolag (publ) in July 2015. The company was founded in 1983 and is headquartered in Gothenburg, Sweden.
Slottsviken Fastighetsaktiebola’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.